You are here

  • Home
  • Archive
  • Volume 77, Issue 2
  • The evolving role of the rheumatologist in the management of immune-related adverse events (irAEs) caused by cancer immunotherapy

Article metrics

Article menu
Download PDFPDF
Viewpoint
The evolving role of the rheumatologist in the management of immune-related adverse events (irAEs) caused by cancer immunotherapy

 

Online download statistics by month:

Online download statistics by month: September 2017 to October 2024

AbstractFullPdf
Sep 20171287160111
Oct 20175307661
Nov 20171713731
Dec 20171352417
Jan 20181435281176
Feb 2018838130102
Mar 20183908455
Apr 20182454930
May 20182271815
Jun 20181613427
Jul 20181202314
Aug 20181982917
Sep 20181621511
Oct 20181412723
Nov 20181242619
Dec 20181341513
Jan 20191041410
Feb 2019140128
Mar 20191852719
Apr 2019117138
May 20191541912
Jun 201910054
Jul 201914296
Aug 2019133123
Sep 201910334
Oct 201912489
Nov 20191061110
Dec 20191091711
Jan 20206884
Feb 202081117
Mar 20209345
Apr 20206235
May 20207563
Jun 20204831
Jul 202010254
Aug 20207054
Sep 20207445
Oct 202085175
Nov 20205740
Dec 20206441
Jan 20214113
Feb 20217133
Mar 20215633
Apr 20216832
May 20211610
Jun 2021521
Jul 2021531
Aug 2021620
Sep 20211281
Oct 20213180
Nov 20213280
Dec 20216552
Jan 20224620
Feb 20223352
Mar 20224401
Apr 20225232
May 20228810
Jun 20226730
Jul 20225292
Aug 202277101
Sep 20226380
Oct 202212362
Nov 20226221
Dec 20223250
Jan 20235062
Feb 202312320
Mar 20233750
Apr 20232040
May 20235140
Jun 20232810
Jul 20237463
Aug 20232241
Sep 20232153
Oct 20235342
Nov 202381120
Dec 20239570
Jan 20246542
Feb 20243310
Mar 20249667
Apr 20248463
May 20244512
Jun 20244770
Jul 20244240
Aug 20245550
Sep 20244441
Oct 20246231
Total110691454924